Abstract Search

ea0079008 | Abstracts | BES2021

Fast-acting insulin aspart improves glucose control in a real-world setting: a 1-year multicenter study in people with type 1 diabetes using continuous glucose monitoring

Lisa Billion , Sara Charleer , Laurens Verbraeken , Mira Sterckx , Kato Vangelabbeek , Block Nathalie De , Charlien Janssen , Dessel Kristof Van , Eveline Dirinck , Frida Peiffer , Nancy Bolsens , Chantal Mathieu , Pieter Gillard , Christophe De Block

Background and Aims: To evaluate whether switching from traditional mealtime insulin analogs to fast-acting insulin aspart (Fiasp) in routine clinical practice is efficacious and safe in adult people with type 1 diabetes (PWD1) using intermittent or real-time continuous glucose monitoring (iCGM or rtCGM).Methods: Data from 438 adult PWD1 (60% men, age 44.6&pm;16.1 years, duration of diabetes 21.5&pm;14.0 years, iCGM/rtCGM: 391/47, injections/pump: 409/29...

0 shares

Endocrine Abstracts

Fast-acting insulin aspart improves glucose control in a real-world setting: a 1-year multicenter study in people with type 1 diabetes using continuous glucose monitoring

BiosciAbstracts